Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstract
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Addendum
Announcement
Art & Psychiatry
Article
Articles
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Commentary
Conference Oration
Conference Summary
Continuing Medical Education
Correspondence
Corrigendum
Cosmetic Dermatology
Cosmetology
Current Best Evidence
Current View
Derma Quest
Dermato Surgery
Dermatopathology
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
e-IJDVL
Editor Speaks
Editorial
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Errata
Erratum
Focus
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
General
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
History
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL AWARDS 2015
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
In Memorium
Inaugural Address
Index
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Medicolegal Window
Messages
Miscellaneous Letter
Musings
Net Case
Net case report
Net Image
Net Letter
Net Quiz
Net Study
New Preparations
News
News & Views
Obervation Letter
Obituary
Observation Letter
Observation Letters
Oration
Original Article
ORIGINAL CONTRIBUTION
Original Contributions
Pattern of Skin Diseases
Pearls
Pediatric Dermatology
Pediatric Rounds
Perspective
Presedential Address
Presidential Address
Presidents Remarks
Quiz
Recommendations
Regret
Report
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Residents' Page
Retraction
Review
Review Article
Review Articles
Revision Corner
Self Assessment Programme
SEMINAR
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Special Article
Specialty Interface
Studies
Study Letter
Supplement-Photoprotection
Supplement-Psoriasis
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
SYMPOSIUM - VITILIGO
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Tables
Technology
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapeutics
Therapy
Therapy Letter
View Point
Viewpoint
What’s new in Dermatology
View/Download PDF
Case Report
2006:72:4;293-295
doi: 10.4103/0378-6323.26727
PMID: 16880577

Anetoderma occurring after hepatitis B vaccination

Marta Teixeira1 , Rosario Alves1 , Aurea Canelhas2 , Manuela Selores1
1 Department of Dermatology, Hospital Geral de Santo Antonio, Porto, Portugal,
2 Department of Pathology, Hospital Geral de Santo Antonio, Porto, Portugal,

Correspondence Address:
Marta Teixeira
Department of Dermatology, Trav. F. Sa Carneiro, 44 3 ET, 4460-677, Leca da Palmeira, Portugal

How to cite this article:
Teixeira M, Alves R, Canelhas A, Selores M. Anetoderma occurring after hepatitis B vaccination. Indian J Dermatol Venereol Leprol 2006;72:293-295
Copyright: (C)2006 Indian Journal of Dermatology, Venereology, and Leprology

Abstract

Anetoderma is an elastolytic disorder of unknown origin. To our knowledge, anetoderma secondary to hepatitis B immunization has been described only once in the literature, in two siblings vaccinated at the same time. We describe, what we believe to be an additional case of such a rare disorder in a 21-year-old man. He presented with white spots and papules on his neck, upper limbs, and trunk, that had developed gradually within the last 6 years without any symptoms. The initial lesions were red macules, which gradually enlarged in size and number, becoming pale. Biopsy of a sack-like lesion revealed normal epidermis, and a discrete mononuclear infiltrate throughout the dermis. Association of anetoderma with hepatitis B vaccination is speculated here, as suggested by history of vaccination two weeks prior to the onset of skin eruption, and ruling out other possible causes of anetoderma.
Keywords: Anetoderma, Engerix B ®, Vaccination

Introduction

Anetoderma is an elastolytic disorder of unknown origin, characterized by circunscribed areas of flaccid skin, which may be depressed macular or papular; the latter can reflect herniation of the subcutaneous tissue.[1] The histology of anetoderma suggests that the basic abnormalilty is focal elastolysis.[2] The mechanism of destruction of the elastic fibers remains unknown. Both cell-mediated and humoral damage have been postulated, but specific anti-elastin reactivity has not yet been shown. Immunologic mechanisms are likely to be important in the pathogenesis of anetoderma, as evidenced by its association with infectious and autoimmune causes. Familial cases have also been described.[3],[4]

Case report

A 21-year-old male was observed for evaluation of white spots and papules on his neck, upper limbs, and trunk, that had developed gradually within the last 6 years without any symptoms. The initial lesions were red macules, which gradually enlarged in size and number, becoming pale. Some of them appeared pouched-out. Our patient consulted us only at this time when he experienced some social constraints, secondary to the skin lesions on exposed areas. He had not noticed any tick bite or migratory erythema. The patient was otherwise in good health, and had no significant past history. No family member was similarly affected.

On examination, multiple, grouped, round to elliptical, well-defined, hypopigmented atrophic macules, papules, and plaques with diameter of 5 to 20 mm were found, distributed on the neck, shoulders, upper limbs, scapular, and pectoral regions [Figure - 1][Figure - 2]. Some of the lesions formed soft sack-like projections. The skin surface appeared thinned and wrinkled. The rest of the physical examination, including ocular fundi, was normal. A diagnosis of anetoderma was postulated.

Biopsy of a sack-like lesion revealed normal epidermis, and a discrete mononuclear infiltrate throughout the dermis. Staining with Verhoeff-van Gieson stain showed loss and disruption of dermal elastic fibers in lesional skin, [Figure - 3] but not in a normal- appearing skin fragment. Direct immunofluorescence in both specimens was negative. Polymerase chain reaction studies failed to detect DNA from Borrelia burgdorferi . Further inquiry revealed that the patient finished the third and last dose of hepatitis B virus (HBV) vaccination two weeks before the skin eruption. The vaccine used was Engerix B ® (Smith Kline Beecham), a recombinant vaccine containing HVB surface antigen (HBsAg ). Hepatitis serology revealed negative HBsAg and anti-HBV core antibody, and positive anti-HBV surface antibody, which confirmed immunity to HBV acquired through vaccination. Hepatitis C serology was negative. Urinalysis, full blood count, ESR and biochemical analysis were normal. Antinuclear antibodies and HIV antibodies were not detected. VDRL and TPHA were negative. Immunoglobulin and complement levels were within normal values. Chest radiograph and tuberculin test were normal. At this stage, the diagnosis of anetoderma subsequent to HBV vaccination was contemplated. Our patient refused treatment.

Discussion

Anetoderma has been classified into primary and secondary forms. Primary anetoderma occurs when there is no underlying associated disorder, and it arises on clinically normal skin. True secondary anetoderma implies that the lesion has appeared at the same site as a previous specific skin lesion. Some authors also consider lesions associated with an underlying disease, as a secondary anetoderma; however, in this case, the atrophic areas do not necessarily develop within areas of known inflammation.[1],[2] Some of the reported associations of secondary anetoderma [Table - 1] may be coincidental, but it is probable that many inflammatory diseases may occasionally be complicated by anetoderma.[1],[3],[4]

Immunization with the HBVAg is effective and safe with an estimated incidence of adverse reactions, either local or systemic, of less than 0.1%. These can be divided into local and systemic ones, and may be due to adjuvants or preservatives of the vaccine. Reactions at the injection site, such as pain, erythema, edema, and induration are common and transient, while others, such as nodules or granulomas, are less common, but may persist. Systemic reactions include anaphylactic reactions, fever, headache, arthralgia, myalgia, serum disease, pericarditis, nephrotic syndrome, and neurological and ophthalmologic complications. Cutaneous side effects are rare, and include urticaria, maculopapular rash, erythema nodosum, erythema multiforme, vasculitis, cryoglobulinemia, periarteritis nodosa, systemic or cutaneous lupus erythematosus, and lichen planus or lichenoid reactions.[5]

Anetoderma occurring after HBV vaccination seems to be a very rare event having been described only once in the literature, in two siblings vaccinated at the same time, 2 weeks after the first of three injections of HBV vaccine.[6] In our patient, the development of the lesions, 2 weeks after the third dose of Engerix ®, is consistent with a T-cell mediated immunologic mechanism, as previously postulated by Daoud et al ,[6] although it might reflect a longer sensitization phase. We believe that HBV vaccination might have been the trigger for the onset of this focal elastolysis.

Various treatments for anetoderma have been proposed.[1],[3],[4] However, most have shown variable short-term results, and the long-term outcome was generally unsuccessful.[1],[3],[4] Cosmetically objectionable areas of anetoderma may be excised.We believe that it is important for physicians to report all adverse reactions after HBV vaccination. However the benefits of the vaccine outweigh its very rare hazards.

References
1.
Maari C, Powell J. Atrophies of connective tisuue. In : Bolognia JL, Jorizzo J, Rapini RP, Horn TD, Mascaro JM, Saurat J, et al , editors. Dermatology. Mosby: St Louis; 2003. p. 1539-48.
[Google Scholar]
2.
Bergman R, Friedman-Birnbaum R, Hazaz B, Cohen E, Munichor M, Lichtig C. An immunofluorescence study of primary anetoderma. Clin Exp Dermatol 1990;15:124-30.
[Google Scholar]
3.
Lewis KG, Bercovitch L, Dill SW, Robinson-Bostom L. Acquired disorders of elastic tissue: Part II. Decreased elastic tissue. J Am Acad Dermatol 2004;51:165-85.
[Google Scholar]
4.
Venencie PY, Winkelmann RK, Moore BA. Anetoderma. Clinical findings, associations and long-term follow-up evaluations. Arch Dermatol 1984;120:1032-9.
[Google Scholar]
5.
McMahon BJ, Helminiak C, Wainwright RB, Bulkow L, Trimble BA, Wainwright K. Frequency of adverse reactions to hepatitis B vaccine in 43,618 persons. Am J Med 1995;98:595-6.
[Google Scholar]
6.
Daoud MS, Dicken CH. Anetoderma after hepatitis B immunization in two siblings. J Am Acad Dermatol 1997;36:779-80.
[Google Scholar]

Fulltext Views
257

PDF downloads
106
Show Sections